STOCK TITAN

Modular Medical (MODD) Stock News, Apr-Jul 2026

MODD NASDAQ

Modular Medical, Inc. reports developments tied to its diabetes-focused medical device business and its Pivot tubeless insulin patch pump. The company is a development-stage insulin delivery technology company using patented technologies to support insulin pump adoption among people with diabetes. Pivot is described as a two-part tubeless patch pump with a removable 3 mL reservoir, disposable battery, and smartphone connectivity for bolus and monitoring.

Recurring MODD news includes FDA 510(k) clearance for Pivot, manufacturing validation, commercial-readiness updates, investor presentations, Nasdaq listing compliance, reverse stock split actions, shareholder voting matters, capital-structure disclosures, governance updates, and operating and financial results.

Rhea-AI Summary

Modular Medical (NASDAQ: MODD) announced a pilot collaboration with IMO Health to build a terminology-powered phenotypic algorithm that identifies diabetes patients who may benefit from Pivot tubeless patch insulin pump therapy directly within electronic health records (EHRs).

The project targets multiple‑daily‑injection patients showing pump hesitancy, prior pump failure, or suboptimal outcomes, using clinician‑guided phenotypes mapped to IMO Health’s validated terminology value sets. Modular Medical plans to pilot the solution at a large‑scale diabetes center and create a scalable framework supporting its expected fourth quarter commercial launch of the Pivot pump.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.67%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ: MODD) reported results from an independent market research study on its FDA-cleared Pivot tubeless patch pump. The research found positive payor receptivity driven by Pivot’s differentiated, simple modular design, tubeless and reusable architecture, 300 IU reservoir, and one-button operation.

According to Modular Medical, payors viewed Pivot favorably for potential reimbursement through pharmacy benefit channels, citing alignment of its disposable component structure and anticipated contracting strategy with existing frameworks. Respondents also indicated interest in strategic partnership models with large healthcare organizations to support broader patient access, evidence generation, and long-term adoption of simplified insulin delivery solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ: MODD) reported results from a diabetes patient research initiative indicating strong demand for simpler insulin pump therapy among multiple daily injection users. In a 100-person assessment, 97% said they would consider pump therapy and were open to alternative treatment options.

The company highlighted unmet needs, including frequent hospitalizations related to severe glycemic events and difficulties finding private places to inject insulin. Modular Medical targets an estimated 4.5 million U.S. patients using both basal and mealtime insulin as the primary market for its Pivot tubeless insulin patch pump and has engaged Thrivable to conduct further research with 20 engaged patients and a 300-person survey.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.02%
Tags
none
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) announced submission to the FDA of software enhancements for its Pivot tubeless insulin patch pump. The update covers increased patient customization, UI improvements and other upgrades. According to Modular Medical, this is the first in a planned series of Pivot platform enhancements, following clearance and market launch of the core form factor.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.00%
Tags
-
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) announced that the first patients have completed training and started using its Pivot™ tubeless insulin patch pump in real-world settings. This marks the transition from development to active patient use and advances its commercialization strategy.

Pivot is described as the first insulin pump specifically designed for the large, underserved population of insulin-dependent adults still using multiple daily injections, a multibillion-dollar market. Modular Medical plans to collect real-world utilization data and user feedback to support broader adoption and optimize product deployment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.79%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ: MODD) announced that Pivot tubeless insulin patch pump starter kits are now shipping to multiple endocrinology practices for physician training. After training, pumps will be offered to potential patients within days and weeks.

The system targets adults on multiple daily injections, an estimated 70% of insulin-dependent adults, described as a multi-billion-dollar opportunity. Full commercial launch is planned in phases, starting with select high-volume endocrinology practices and expanding across select metropolitan markets by late 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.90%
Tags
none
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) announced U.S. commercial availability of its Pivot tubeless insulin patch pump following FDA 510(k) clearance in April. This begins real-world patient use and marks its shift to a commercial-stage, revenue-generating business.

Pivot is the second fully electronic, tubeless insulin pump in the U.S., targeting insulin-dependent adults on multiple daily injections—an estimated 70% of this population and a multi-billion-dollar market. Initial shipments start immediately, with phased commercial expansion from select high-volume endocrinology practices to multiple metropolitan markets by late 2026. Broader commercial activities are expected to ramp in Q4 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.21%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) launched PivotPump.com, a patient-focused site for its Pivot tubeless insulin patch pump. The site supports people exploring insulin pump therapy.

Pivot received FDA clearance in April 2026, with initial patients expected June 2026 and a commercial launch targeted for fall 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.40%
Tags
none
-
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) announced a free webinar titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch" featuring CEO Jeb Besser on May 1, 2026 at 8:00 AM PT / 11:00 AM ET.

The event will include a presentation and live Q&A hosted by Tribe Public; registration is available at MODD-May-Watch.TribePublic.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.25%
Tags
none
Rhea-AI Summary

Modular Medical (NASDAQ:MODD) priced a registered direct offering of 750,000 shares at $4.50 per share, generating estimated gross proceeds of ~$3.4 million before fees. The offering is expected to close on or about April 21, 2026, subject to customary closing conditions. Maxim Group is sole placement agent. The shares will be offered under a shelf registration statement on Form S-3 declared effective May 22, 2025; a prospectus supplement will be filed with the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.68%
Tags

FAQ

What is the current stock price of Modular Medical (MODD)?

Modular Medical (MODD) last closed at $1.91.

What is the market cap of Modular Medical (MODD)?

The market cap of Modular Medical (MODD) is approximately $18.1M.